(Q41684151)

7 October 2017

1 reference

title

Interleukin-10: biology, role in inflammation and autoimmunity (English)

1 reference

7 October 2017

Lalani I

1

1 reference

PubMed ID

9433360

7 October 2017

Bhol K

series ordinal

2

1 reference

PubMed ID

9433360

7 October 2017

Ahmed AR

series ordinal

3

1 reference

7 October 2017

1 December 1997

1 reference

Annals of Allergy, Asthma & Immunology

7 October 2017

1 reference

7 October 2017

79

1 reference

7 October 2017

469-483

1 reference

7 October 2017

6

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 October 2017

1 reference

7 January 2021

Disulfide bond assignments and secondary structure analysis of human and murine interleukin 10

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Sequence of the sheep interleukin-10-encoding cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Receptors for interleukin (IL)-10 and IL-6-type cytokines use similar signaling mechanisms for inducing transcription through IL-6 response elements

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Interleukin-10 stimulation of phosphatidylinositol 3-kinase and p70 S6 kinase is required for the proliferative but not the antiinflammatory effects of the cytokine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

An investigation of polymorphism in the interleukin-10 gene promoter.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Biological properties of interleukin 10.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Interleukin 10: a novel stimulatory factor for mast cells and their progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Synthesis of type 1 (IFN gamma) and type 2 (IL-4, IL-5, and IL-10) cytokines by human eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Human and viral interleukin-10 in Hodgkin's disease, and its influence on CD4+ and CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Interleukin-10 induces interleukin-11 responsiveness in human myeloma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Active specific immunotherapy with hapten-modified autologous melanoma cell vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Substance P augments interleukin-10 and tumor necrosis factor-alpha release by human cord blood monocytes and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Interferon effects on interleukin-10 secretion. Mononuclear cell response to interleukin-10 is normal in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Suppressive effect of transforming growth factor beta1 on the recurrence of experimental melanin protein-induced uveitis: upregulation of ocular interleukin-10.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Interferon gamma inhibits interleukin 10 production by monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Characterisation of monoclonal antibodies against human interleukin-10 and their use in an ELISA for the measurement of this cytokine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Quantitative measurement of human cytokine gene expression by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

A sensitive and specific bioassay for the detection of human interleukin-10.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Models of T cell anergy: is there a common molecular mechanism?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysacchari

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

The role of nitric oxide in parasitic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Macrophage deactivation by interleukin 10

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Interleukin-10-deficient mice develop chronic enterocolitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Role of cytokines in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Expression of interferon-gamma (IFN-gamma), IL-10, IL-12 and transforming growth factor-beta (TGF-beta) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Interleukin-10 inhibition of the progression of established collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-gamma-secreting cells in the peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Cytokines and the pathogenesis of myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Retrobulbar T cells from patients with Graves' ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Differential interleukin (IL)-10 and IL-13 gene expression in vivo in salivary glands and peripheral blood mononuclear cells from patients with primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

1,25-(OH)2-vitamin D3 and calcipotriol induce IL-10 receptor gene expression in human epidermal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Studies with IL-10-/- mice: an overview.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Increased serum interleukin-10 level in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

The eosinophilic leukocyte: structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

CD40 expression by human peripheral blood eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Dual action of IL-4 on mite antigen-induced IgE synthesis in lymphocytes from individuals with bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Interleukin-10 regulation in normal subjects and patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Increased interleukin-10 messenger RNA expression in atopic allergy and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Anti-inflammatory effects of theophylline: modulation of cytokine production

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Circulating interleukin 10 and interleukin-6 serum levels in rheumatoid arthritis patients treated with methotrexate or gold salts: preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Molecular and cellular events implicated in local tolerance to kidney allografts in miniature swine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Molecular identification of porcine interleukin 10: regulation of expression in a kidney allograft model

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Nerve growth factor induces the expression of certain cytokine genes and bcl-2 in mast cells. Potential role in survival promotion

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

A dual mechanism of immunosuppression by FK-506. Differential suppression of IL-4 and IL-10 levels in T helper 2 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Combined effects of FK506 (tacrolimus) and cyclophosphamide on atypical B220+ T cells, cytokine gene expression and disease activity in MRL/MpJ-lpr/lpr mice

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Impaired T-cell IL-10 secretion and CD4 helper function in liver transplant patients treated with tacrolimus

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Methotrexate treatment in murine experimental systemic lupus erythematosus (SLE); clinical benefits associated with cytokine manipulation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

Enhancement of endotoxin-induced interleukin-10 production by SR 31747A, a sigma ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

BTS 71 412: in vitro profile of a novel pyrazolinone immunosuppressant

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963052-9

7 January 2021

10.1016/S1081-1206(10)63052-9

Identifiers

DOI

1 reference

7 October 2017

1 reference

PubMed ID

9433360